Research
Search
Close
SHENG Xiaohua
- Chief Physician, Graduate Supervisor
- Department: Nephrology
- Research Area: Nephrology
- Research Interests: Blood Purification
- Contact: xiaohuasheng400@msn.com
- Fellowship, The International Renal Research Institute of Vicenza, 2019
- MD from Soochow University, 2020
- MM from Shanghai Jiao Tong University School of Medicine, 2010
- BM from Shanghai Second Medical University, 1997
- Chief Physician, Department of Nephrology, Shanghai Sixth People's Hospital
- Director, Blood Purification Center, Shanghai Sixth People's Hospital
- Xiaohua Sheng; Jingye Yang; Gang Yu; Yang Fei; Hongda Bao; Jianyong Yin; Weifeng Huang; Zebo Tian; Niansong Wang; Claudio Ronco ; Procalcitonin and N-Terminal Pro-B-Type Natriuretic Peptide for Prognosis in Septic Acute Kidney Injury Patients Receiving Renal Replacement Therapy, Blood Purification, 2019, 48(3): 262-271
- Li-Ming Wei; Gang Yu; Hong-Wei Bao; Hai-Tao Lu; Xiao-Hua Sheng; Yue-Qi Zhu ; Accuracy of 3.0T magnetic resonance angiography for the detection of arteriovenous fistula dysfunction in hemodialysis patients requiring interventional therapy: a prospective study, Quantitative Imaging in Medicine and Surgery, 2024, 14(4): 2788-2799
- Li, Junhui; Sheng, Xiaohua; Cheng, Dongsheng; Wang, Feng; Jian, Guihua; Li, Yongguang; Xu, Tao; Wang, Xiaoxia; Fan, Ying; Wang, Niansong ; Is the mean platelet volume a predictive marker of a high in-hospital mortality of acute cardiorenal syndrome patients receiving continuous renal replacement therapy?, MEDICINE, 2018, 25(97): e11180
- Zeng C, Cheng D, Sheng X,Jian G, Fan Y, Chen Y, Li J, Bao H, Wang N. Increased Serum Uric Acid Level Is a Risk Factor for Left Ventricular Hypertrophy but Not Independent of eGFR in Patients with Type 2 Diabetic Kidney Disease. J Diabetes Res. 2017:5016093.
- Jia L, Sheng X, Zamperetti A, Xie Y, Corradi V, Chandel S, De Cal M, Montin DP, Caprara C, Ronco C. Combination of biomarker with clinical risk factors for prediction of severe acute kidney injury in critically ill patients. BMC Nephrol.
- 11/2023-10/2027
National Key Research and Development Program of China, ¥500,000, 2023YFC2411805
Development of portable CRRT equipment
Role: Sub-center Principal Investigator
